Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A. L. Cox is active.

Publication


Featured researches published by A. L. Cox.


The Journal of Thoracic and Cardiovascular Surgery | 1994

Exercise cardiorespiratory function before and one year after operation for pectus excavatum

W. J. Morshuis; Hans T. Folgering; Jelle Barentsz; A. L. Cox; Henk J. J. Van Lier; Leon K. Lacquet

In 35 patients with pectus excavatum (aged 17.9 +/- 5.6 years) pulmonary function and maximal exercise test results were compared before and at 1 year after operation. The lower posteroanterior chest diameter on the lateral x-ray film was significantly smaller than normal (p < 0.0001) and increased significantly after operation (p < 0.0001). Preoperatively, total lung capacity (86.0% +/- 14.4%; p = 0.0001) and inspiratory vital capacity (79.7% +/- 16.2; p = 0.0001) were significantly smaller than predicted and further decreased after operation (-9.2% +/- 9.2%; p = 0.0001 and -6.6% +/- 10.7%; p = 0.0012, respectively). Arterial blood gas values displayed normal patterns with increasing exercise both before and after operation. Only the arterial pH decreased more after operation than before (p = 0.0026). After operation there was a significant increase in maximal oxygen uptake (oxygen uptake; p = 0.0002 and oxygen uptake per kilogram; p = 0.0025) and oxygen pulse (oxygen uptake/heart rate approximates an indirect parameter for stroke volume; p = 0.0333) during exercise, whereas the maximal work performed was unchanged. Efficiency of breathing (ratio of tidal volume/inspiratory vital capacity) at maximal exercise improved significantly after operation (p = 0.0005). Ventilatory limitation of exercise (defined by an increase in carbon dioxide tension during exercise) was found in 43.9% of the patients before operation. A tendency of improvement was noted (not significant) after operation (difference in carbon dioxide tension 0.6 +/- 0.4 kPa before versus 0.3 +/- 0.5 kPa after operation). However, the group with normal preoperative carbon dioxide elimination had a ventilatory limitation of exercise after operation (difference in carbon dioxide tension -0.4 +/- 0.3 kPa before versus -0.1 +/- 0.3 kPa after operation; p = 0.0128) with a significant increase in oxygen consumption (p = 0.0007). In conclusion the subjective physical improvement after operation is not explained by changes in cardiorespiratory function at exercise. The data suggest a higher work of breathing after operation.


The Annals of Thoracic Surgery | 1993

Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer

Rob J. van Klaveren; Jan Festen; Henk J.A.M. Otten; A. L. Cox; Ruurd de Graaf; Leon K. Lacquet

Of 111 patients with non-small cell lung cancer without clinically evident N2 disease 95 underwent mediastinoscopy between 1975 and 1985. In 63 cases mediastinoscopy was positive and in 32 negative. The patients with a positive mediastinoscopy were considered to have inoperable disease. Their 3- and 5-year survival rates were 5% and 0%, respectively. The patients with a negative mediastinoscopy and 16 patients in whom no mediastinoscopy was performed because of a peripheral tumor underwent operation. They underwent complete tumor resection and mediastinal lymph node dissection. Unsuspected N2 disease was found. Their 3- and 5-year survival rates were 19% and 10%, respectively. The better survival rate in the operated group was statistically significant and mainly due to a better survival of the lobectomy group. Multiple regression analysis showed no favorable prognostic factors in the nonoperated group, but in the operated group lobectomy and central location of the tumor significantly improved the prognosis. We conclude that patients with unsuspected stage IIIa non-small cell lung cancer discovered at thoracotomy benefit from complete tumor resection and mediastinal lymph node dissection, especially if the resection can be confined to lobectomy and if the tumor is located centrally.


European Journal of Cardio-Thoracic Surgery | 1992

Pectus excavatum: a clinical study with long-term postoperative follow-up

W. J. Morshuis; H. Mulder; G. Wapperom; H.T.M. Folgering; M. Assman; A. L. Cox; H. J. Van Lier; Josef G. Vincent; Leon K. Lacquet

Between 1972 and 1987, 192 patients have been operated upon for pectus excavatum of which 152 patients were included in the study (79%). Mean age at operation was 15.3 +/- 5.5 years; 117 were male. Mean follow-up was 8.1 +/- 3.6 years. The deformity was noted before the age of 5 in 90%. Type I symmetrical and localized deformity was seen in 33.2%, type II symmetrical but diffuse depression in 23.7% and type III localized or diffuse asymmetrical deformity in 43.1%. It was considered severe in 68.9%, fair in 16.9% and mild in 14.2%. There were significantly more asymmetrical defects in the older age groups. The operation consisted of subperichondral chondrectomy, transverse sternotomy and division of the intercostal bundles at the outer limit of the chondrectomy and suturing the edge of this broad sheet of muscle and perichondrium to the anterior surface of the chest wall more laterally and under tension, elevating and stabilizing the sternum. Results were satisfactory in 83.6% (excellent 44.1%, good 39.5%). Results were not significantly influenced by age, sex, severity, type, symmetry, the extent of cartilage resection or follow-up. Results were inversely influenced by the occurrence of wound problems. The optimal age for operation is considered to be between 5 and 10 years. Both physical as well as psychological cosmetic factors may serve as an indication for operation.


Journal of Clinical Oncology | 1998

Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.

Vivianne C. G. Tjan-Heijnen; Bonne Biesma; Jan Festen; Ted A.W. Splinter; A. L. Cox; D J Wagener; Pieter E. Postmus

PURPOSE To evaluate the impact of granulocyte colony-stimulating factor (G-CSF) priming on peripheral-blood cell counts during standard-dose chemotherapy. PATIENTS AND METHODS Twelve patients with relapsed small-cell lung carcinoma (SCLC) were treated with two chemotherapy courses. Six patients received G-CSF priming only before the first course (group A) and the other six patients only before the second course (group B). Each patient served as his own control. Patients were treated with cyclophosphamide, epirubicin, and etoposide (CEE), or with vincristine, ifosfamide, mesna, and carboplatin (VIMP) every 4 weeks. G-CSF was administered subcutaneously 5 microg/kg/d for 6 days until 48 hours before the first or second chemotherapy course. RESULTS Priming caused a lowering of the WBC nadir, with a median value of 0.95 x 10(9)/L (P = .004), and of absolute neutrophil nadir, with a median value of 0.48 x 10(9)/L (P = .03). There was a trend for a lower platelet (PLT) nadir after G-CSF priming (P = .09). G-CSF priming resulted in a prolonged duration of WBC count less than 3.0 x 10(9)/L of +4.25 days (P = .04), and of WBC count less than 1.0 x 10(9)/L of +0.50 days (P = .03). The duration of neutropenia less than 0.5 x 10(9)/L seemed longer in primed courses (+3.75 days, P = .18). The duration of PLT counts less than 100 x 10(9)/L was prolonged by 1.5 days (P = .04). Hemoglobin (Hgb) levels were not influenced by G-CSF priming. CONCLUSION G-CSF administration until 48 hours before the next chemotherapy course increases chemotherapy-associated leukocytopenia and thrombocytopenia. This may be of special concern when G-CSF is administered during dose-densified chemotherapy.


Thorax | 1994

Mesenchymal cystic hamartoma of the lung: a rare cause of relapsing pneumothorax

R.J. van Klaveren; H H M Hassing; J M Wiersma-van Tilburg; Leon K. Lacquet; A. L. Cox

A 14 year old boy is described with recurrent spontaneous pneumothoraces due to a mesenchymal cystic hamartoma, a very rare disease with a multicentric nature and a benign course in most patients.


Thorax | 1992

Congenital bronchial atresia with regional emphysema associated with pectus excavatum

R.J. van Klaveren; W. J. Morshuis; Leon K. Lacquet; A. L. Cox; J. Festen; F. M. J. Heystraten

Two cases of congenital bronchial atresia with pectus excavatum are reported. Costosternal retraction during the efforts to overcome the airway obstruction due to encroachment on normal lung tissue by the hyperinflated segments may play a part in causing pectus excavatum.


European Radiology | 1994

Chest radiography in pectus excavatum: Recognition of pectus excavatum-related signs and assessment of severity before and after surgical correction

W. J. Morshuis; Jelle Barentsz; Leon K. Lacquet; H.T.M. Folgering; J. G. Mulder; H. J. J. Van Lier; A. L. Cox

A combined retrospective and prospective study describes findings on posteroanterior (PA) chest films and evaluates objective measurements on lateral chest films in pectus excavatum, both before and after surgical correction. Dispiacement of the heart to the left was seen in more than 50%, of patients and was significantly less predominant 1 year after operation, whereas other signs resulting from compression by the anterior chest wall remained unchanged or needed more time to be resolved. In both study groups the lower vertebral index and upper vertebral index in pectus excavatum patients was higher than predicted (P < 0.0001), reflecting smaller PA diameters of the chest. The diameters increased after operation (P < 0.0001), especially the lower. A significant relation was found between clinical severity and radiologic depth of depression. There was no significant relation between clinical operative result and radiologic postoperative changes in chest diameters.


Clinical Infectious Diseases | 1997

Pleural Empyema Due to Clostridium difficile and Clostridium cadaveris

Virginia Stolk-Engelaar; Jeroen Verwiel; Ger P. A. Bongaerts; Vic Linsen; Leon K. Lacquet; A. L. Cox


The Journal of Thoracic and Cardiovascular Surgery | 1994

A symptomatic thymic cyst in the middle mediastinum.

R.J. van Klaveren; J. Festen; Leon K. Lacquet; J.M. Wiersma-Tilburg; A. L. Cox


Journal of Clinical Oncology | 1999

Detrimental Effects of Prechemotherapy Filgrastim

Stefan Serke; Dieter Huhn; Hans Eric Johnsen; Richard Herrmann; Vivianne C. G. Tjan-Heijnen; Bonne Biesma; Jan Festen; Ted A.W. Splinter; A. L. Cox; D.J. Theo Wagener; Pieter E. Postmus

Collaboration


Dive into the A. L. Cox's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

H.T.M. Folgering

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar

Pieter E. Postmus

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

R.J. van Klaveren

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Ted A.W. Splinter

Erasmus University Rotterdam

View shared research outputs
Top Co-Authors

Avatar

Vivianne C. G. Tjan-Heijnen

Maastricht University Medical Centre

View shared research outputs
Top Co-Authors

Avatar

H. J. J. Van Lier

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Josef G. Vincent

Radboud University Nijmegen

View shared research outputs
Researchain Logo
Decentralizing Knowledge